NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,480,000 | -64.9% | 12,741 | -33.0% | 0.19% | -29.1% |
| Q2 2021 | $4,216,000 | +261.6% | 19,008 | +37.3% | 0.27% | +3.5% |
| Q1 2020 | $1,166,000 | -50.0% | 13,840 | -50.0% | 0.26% | -42.2% |
| Q4 2019 | $2,332,000 | +137.5% | 27,680 | +110.8% | 0.45% | +4.9% |
| Q3 2019 | $982,000 | -25.8% | 13,133 | -37.3% | 0.43% | -22.8% |
| Q2 2019 | $1,324,000 | +0.4% | 20,936 | -23.6% | 0.55% | +17.2% |
| Q1 2019 | $1,319,000 | – | 27,391 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |